Inovio Pharmaceuticals CEO J Kim's 2011 pay jumps 72% to $904K
Inovio Pharmaceuticals reports 2011 executive compensation
By ExecPay News
Published: April 6, 2012
Inovio Pharmaceuticals reported fiscal year 2011 executive compensation information on April 6, 2012.
In 2011, six executives at Inovio Pharmaceuticals received on average a compensation package of $563K, a 1% increase compared to previous year.
Average pay of disclosed executives at Inovio Pharmaceuticals
J. Joseph Kim, Chief Executive Officer, received $904K in total, which increased by 72% compared to 2010. 47% of Kim's compensation, or $422K, was in salary. Kim also received $238K in bonus, $235K in option awards, as well as $8.3K in other compensation.
Avtar Dhillon, Chairman, received a compensation package of $657K, which decreased by 24% compared to previous year. 45% of the compensation package, or $296K, was in salary.
Niranjan Y. Sardesai, Chief Operating Officer, earned $460K in 2011.
Niranjan Y. Sardesei, Chief Operating Officer, received $460K in 2011.
Peter D. Kies, Chief Financial Officer, earned $453K in 2011, a 60% increase compared to previous year.
Mark L. Bagarazzi, Chief Medical Officer, received $445K in 2011.
Related executives
Avtar Dhillon
Inovio Pharmaceuticals
Chairman
J Kim
Inovio Pharmaceuticals
Chief Executive Officer
Mark Bagarazzi
Inovio Pharmaceuticals
Chief Medical Officer
Peter Kies
Inovio Pharmaceuticals
Chief Financial Officer
Niranjan Sardesai
Inovio Pharmaceuticals
Chief Operating Officer
Niranjan Sardesei
Inovio Pharmaceuticals
Chief Operating Officer
You may also like
Source: SEC filing on April 6, 2012.